Vítor S. Tardelli

578 total citations
28 papers, 324 citations indexed

About

Vítor S. Tardelli is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Vítor S. Tardelli has authored 28 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 8 papers in Pharmacology and 8 papers in Psychiatry and Mental health. Recurrent topics in Vítor S. Tardelli's work include Opioid Use Disorder Treatment (13 papers), Attention Deficit Hyperactivity Disorder (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Vítor S. Tardelli is often cited by papers focused on Opioid Use Disorder Treatment (13 papers), Attention Deficit Hyperactivity Disorder (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Vítor S. Tardelli collaborates with scholars based in Brazil, Canada and United States. Vítor S. Tardelli's co-authors include Thiago Marques Fidalgo, Adam Bisaga, Gilberto Gerra, Frances R. Levin, Sílvia S. Martins, Dartiu Xavier da Silveira, Elisa Brietzke, Julián Santaella-Tenorio, Luís Eduardo Coelho Andrade and Tais Moriyama and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Public Health and Behaviour Research and Therapy.

In The Last Decade

Vítor S. Tardelli

23 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vítor S. Tardelli Brazil 10 96 84 84 65 60 28 324
Anthony Glasper United Kingdom 10 106 1.1× 62 0.7× 110 1.3× 51 0.8× 74 1.2× 11 385
Carlos Tirado United States 9 69 0.7× 114 1.4× 102 1.2× 81 1.2× 60 1.0× 20 318
Arthur N. Westover United States 8 98 1.0× 61 0.7× 117 1.4× 96 1.5× 141 2.4× 12 548
Martin Lieb Germany 9 93 1.0× 40 0.5× 67 0.8× 61 0.9× 55 0.9× 21 323
Alfio Lucchini Italy 10 98 1.0× 78 0.9× 109 1.3× 50 0.8× 47 0.8× 20 370
Britahny M. Baskin United States 6 54 0.6× 84 1.0× 107 1.3× 41 0.6× 25 0.4× 12 260
Raj K. Kalapatapu United States 9 63 0.7× 47 0.6× 68 0.8× 46 0.7× 56 0.9× 31 281
Pertti Heikman Finland 10 114 1.2× 52 0.6× 64 0.8× 116 1.8× 82 1.4× 16 348
Felipe Castillo United States 10 102 1.1× 103 1.2× 114 1.4× 34 0.5× 21 0.3× 20 358
Marina Tsoy Russia 9 114 1.2× 149 1.8× 208 2.5× 60 0.9× 61 1.0× 9 482

Countries citing papers authored by Vítor S. Tardelli

Since Specialization
Citations

This map shows the geographic impact of Vítor S. Tardelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vítor S. Tardelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vítor S. Tardelli more than expected).

Fields of papers citing papers by Vítor S. Tardelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vítor S. Tardelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vítor S. Tardelli. The network helps show where Vítor S. Tardelli may publish in the future.

Co-authorship network of co-authors of Vítor S. Tardelli

This figure shows the co-authorship network connecting the top 25 collaborators of Vítor S. Tardelli. A scholar is included among the top collaborators of Vítor S. Tardelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vítor S. Tardelli. Vítor S. Tardelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tardelli, Vítor S., et al.. (2025). Intentional Drug Overdose Deaths and Mood Disorders in Brazil - A 20-Year Overview. Drug and Alcohol Dependence. 267. 111453–111453.
2.
Xu, Kevin Y., Richard A. Grucza, Vítor S. Tardelli, Patrick D. Quinn, & Jeffrey F. Scherrer. (2025). Opioid and stimulant co-prescribing does not equate to a co-epidemic. The Lancet Regional Health - Americas. 45. 101093–101093.
3.
Santaella-Tenorio, Julián, Thiago Marques Fidalgo, Vítor S. Tardelli, et al.. (2024). Trends in Nonfatal Overdose Rates Due to Alcohol and Prescription and Illegal Substances in Colombia, 2010–2021. American Journal of Public Health. 114(11). e1–e9.
4.
Kim, Soyeon, et al.. (2023). The COVID‐19 impact and characterization on substance use‐related emergency department visits for adolescents and young adults in Canada: Practical implications. Journal of Evaluation in Clinical Practice. 29(3). 447–458. 7 indexed citations
5.
Sharafi, Heidar, Sarah Drouin, Stephanie Coronado‐Montoya, et al.. (2023). Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials. Addiction. 119(2). 211–224. 9 indexed citations
6.
Tardelli, Vítor S., Kelsy Catherina Nema Areco, Paulo Bandiera‐Paiva, et al.. (2023). Drug overdose deaths in Brazil between 2000 and 2020: an analysis of sociodemographics and intentionality. Brazilian Journal of Psychiatry. 45(5). 405–413. 3 indexed citations
7.
Tardelli, Vítor S., et al.. (2023). Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach. Addiction Biology. 28(4). e13271–e13271. 9 indexed citations
8.
Sharafi, Heidar, Arash Bahremand, Sarah Drouin, et al.. (2023). Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials. Drug and Alcohol Dependence. 253. 111018–111018. 3 indexed citations
9.
Tardelli, Vítor S., et al.. (2023). Can Contingency Management Solve the Problem of Adherence to Antiretroviral Therapy in Drug-Dependent Individuals?. Health Education & Behavior. 50(6). 738–747. 3 indexed citations
10.
Tardelli, Vítor S., Kevin Y. Xu, Adam Bisaga, et al.. (2023). Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk. SHILAP Revista de lepidopterología. 26(1). e300728–e300728. 6 indexed citations
11.
Bozinoff, Nikki, et al.. (2022). Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review. Harm Reduction Journal. 19(1). 113–113. 2 indexed citations
12.
Tardelli, Vítor S., et al.. (2022). Overdose deaths involving non-BZD hypnotic/sedatives in the USA: Trends analyses. The Lancet Regional Health - Americas. 10. 100190–100190. 17 indexed citations
13.
Tardelli, Vítor S., Sílvia S. Martins, & Thiago Marques Fidalgo. (2020). Differences in use of inhalants among sexual minorities in the USA in 2015–2018. Addictive Behaviors. 115. 106789–106789. 8 indexed citations
14.
Tardelli, Vítor S., et al.. (2020). Cannabis and Inflammatory Mediators. European Addiction Research. 27(1). 16–24. 20 indexed citations
15.
Tardelli, Vítor S., et al.. (2020). Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. Psychopharmacology. 237(8). 2233–2255. 80 indexed citations
16.
Tardelli, Vítor S., et al.. (2020). The SARS-Cov-2 threat in Cracolândia, an open-air drug use scene in Brazil. International Journal of Drug Policy. 83. 102835–102835. 3 indexed citations
17.
Tardelli, Vítor S., Thiago Marques Fidalgo, & Sílvia S. Martins. (2020). How do medical and non-medical use of z-drugs relate to psychological distress and the use of other depressant drugs?. Addictive Behaviors. 112. 106606–106606. 4 indexed citations
18.
Tardelli, Vítor S., Thiago Marques Fidalgo, Julián Santaella-Tenorio, & Sílvia S. Martins. (2019). Medical use, non-medical use and use disorders of benzodiazepines and prescription opioids in adults: Differences by insurance status. Drug and Alcohol Dependence. 204. 107573–107573. 15 indexed citations
19.
Tardelli, Vítor S., et al.. (2018). Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review. Behaviour Research and Therapy. 111. 57–63. 17 indexed citations
20.
Moriyama, Tais, André C. Felício, Marcos Hortes Nisihara Chagas, et al.. (2011). Increased dopamine transporter density in Parkinson's disease patients with social anxiety disorder. Journal of the Neurological Sciences. 310(1-2). 53–57. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony Glasper Breakdown of academic impact, for papers by Carlos Tirado Breakdown of academic impact, for papers by Arthur N. Westover Breakdown of academic impact, for papers by Martin Lieb Breakdown of academic impact, for papers by Alfio Lucchini Breakdown of academic impact, for papers by Britahny M. Baskin Breakdown of academic impact, for papers by Raj K. Kalapatapu Breakdown of academic impact, for papers by Pertti Heikman Breakdown of academic impact, for papers by Felipe Castillo Breakdown of academic impact, for papers by Marina Tsoy
Rankless by CCL
2026